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1. INTRODUCTION 
1.1. Laser treatment of scars 
The use of lasers to treat atrophic scarring conditions in darker skin 
types presents a significant challenge to laser practitioners.   
Treatment options are limited due to increased risks of pigmentary 
complications including hypo- and hyper-pigmentation. This is 
especially true when attempting to treat large areas with atrophic 
scarring.   
Post chickenpox scars are usually more common in adults and its 
treatment represents a major challenge for cosmetic dermatologists. 
Current methods of treating scarring include traditional fully ablative 
erbium and carbon dioxide (CO2) treatments as well as non-ablative 
and ablative fractional resurfacing with CO2, erbium:yttrium-
aluminum-garnet (Er:YAG), and erbium:yttrium-scandium-galium-
garnet (Er:YSGG) lasers. These options can be challenging for skin 
type IV patients and not feasible for patients with skin types V and 
VI without significant pre- and post-treatment skin conditioning and 
a hyper-pigmentation risk. With traditional fully ablative CO2 
resurfacing, studies showed hyper-pigmentation rates of 20% to 30% 
in Fitzpatrick skin type III and nearly 100% in skin type IV if 
treatment is performed without pre-treatment prophylaxis. Further, 
19% of traditional resurfacing patients experience some form of 
hypo-pigmentation.  A recent study on the treatment of acne scarring 
with fractionated Er:YAG laser reported a Post inflammatory 
Hyperpigmentation (PIH)  incidence of 50% in 15 subjects with skin 
types IV-VI.   
When the 1064 nm neodymium-doped yttrium aluminum garnet 
(Nd:YAG)  laser  with  the  option  of  sub-millisecond  pulse  width  is   
used with 300-500 micro second pulse durations, a 5 mm spot size 
and repetition rates of 5-10 Hz, it offers the ability to focus heat in 
the papillary and upper reticular dermis.  The sub-millisecond 1064 
nm Nd:YAG laser has been proven to stimulate new collagen 
synthesis.  It is therefore feasible that deliberate sub-millisecond 
1064 nm Nd:YAG laser treatments could result in substantial 
reduction in scarring by stimulating collagen formation resulting in 
smoothing of the skin.  
 
1.2. Laser treatment of warts  
Warts are benign epithelial neoplasm of the skin and mucosa 
resulting from human papilloma virus infection. They are a common 
dermatologic complaint, with an estimated incidence of 10% in 
children and young adults.  
Verruca plana (flat warts) are less exophytic than common warts, 
frequently presenting as several or dozen of subtle papules 2–6 mm 
in diameter elevated above the surface less than a millimetre or so. 
These can be quite subtle, and may be missed by a casual observer. 
Pigmentary disturbances may be the most disturbing part of the flat 
wart infection to the patient. These lesions are frequently a problem 
on the face and the glabrous skin of non-immunocompromised 
individuals. At present, therapies aim to remove the lesion rather 
than specifically target human papillomavirus infection. 
The four morphologic types of genital warts are condylomata 
acuminata, which have a cauliflowerlike appearance; papular warts, 
which are fleshcolored, dome-shaped papules, usually 1–4 mm in 
diameter; keratotic warts, which have a thick, crust-like layer and 
may resemble common skin warts or seborrheic keratosis; and flat-
topped papules, which appear macular to slightly raised. 
In general, condylomata are most frequently detected on moist, 
partially keratinized epithelium, papular and keratotic warts on fully 
keratinized epithelium, and flat papular warts on either partially or 
fully keratinized epithelium. Treatment of warts can be difficult, 
with most approaches relying on physical destruction of infected 
keratinocytes. Common therapeutic approaches include liquid 
nitrogen, cryotherapy, topically applied acids, electro surgery, 
cantharidin application, bleomycin injection. Genital wart therapies 
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are classified as patient-applied or provider-administered. Patient-
applied treatments include podofilox solution and gel, and 
imiquimod cream. To self-treat, patients must be able to identify and 
reach the warts and to follow the treatment application instructions. 
The provider-administered treatments include topical treatments 
(cryotherapy, podophyllin resin, trichloroacetic acid, bichloroacetic 
acid, and external application and intraurethral instillation of bacillus 
Calmette–Guerin); excisional treatments (curettage, electrosurgery, 
scissors excision, cryosurgery and laser therapy); or injectable 
treatments (interferon or 5-fluorouracil/epinephrine gel implant). 
Many types of lasers have been used for the management of warts. 
Carbon dioxyde laser vaporization for infected tissue was used. 
Tuncel et al. used the pulsed dye laser (PDL) for treatment of 
perianal warts in children. They found the pulsed dye laser to be 
effective and less traumatic compared with other treatment options. 
To date, there have been no trial evaluating the efficacy of long 
pulsed Nd-YAG laser in the treatment of common warts. 
 
 
2. AIMS 
The primary objective of our retrospective study was to determine 
the safety and efficacy of the unique pulse modality of 
submillisecond to reduce the signs of atrophic scarring, texture and 
PIH secondary to the acne condition in darker skin types. The 
secondary objective is to assess the incidence of PIH resulting from 
the laser treatments. As the post chickenpox scars are representing a 
clinical and therapeutic challange specially in dark skin so we also 
wanted to evaluate the safety and efficacy of using 
Microdermabrasion (MDA) and the sub-millisecond 1064 nm 
Nd:YAG laser in facial chickenpox scarring cases in adult men with 
skin type IV and V. Our further aim was to determine the safety and 
efficacy of the flashlamp pumped pulsed dye laser for the treatment 
of  uncomplicated  genital  warts  in  adult  males  and  the  safety  and  
efficacy of Nd:YAG laser in treatment of plane warts. 
 
3. PATIENTS AND METHODS 
3.1.  Treatments of scars       
3.1.1. Scar treatment in dark skin    
    
STUDY DESIGN AND METHODS: 
This is a retrospective study evaluating the safety and efficacy of a 
sub-millisecond 1064 nm Nd:YAG laser. Treatments were 
conducted at the National Institute of Laser Enhanced Sciences, 
Dermatology Unit, at Cairo University, Egypt and at Saheroun 
Hospital, Khartoum, Sudan on 22 patients with Fitzpatrick skin types 
III (n =  2),  IV  (n =  4),  V  (n =  14),  VI  (n = 2) who had atrophic 
scarring such as acne scarring.  All patients who were treated over a 
six month period between February and July of 2008 were included 
in the study.   
Treatments were performed using 300-500 µs pulse duration, 14-16 
J/cm2 and 5-7 Hz repetition rate. The hand piece was held 1-2 cm off 
the surface of the skin (about the width of an index finger) during 
delivery.  Treatments were performed without topical anesthesia.  No 
prophylactic therapy was used before or after treatment to control 
PIH resulting from laser treatments. On average, each patient 
received 6 treatments (minimum 5, maximum 7). The average 
interval between treatments was 24.5 days with a range from 18.7 to 
33.0 days.  Follow-up photographs were taken, on average, 9 months 
(range  of  3  to  10  months)  after  the  final  treatment.  Patient  ages  
ranged from 18 – 47 years with a mean of 28.6 years. The average 
number of pulses per procedure was 11,700 pulses ranging from 
8,000 to 13,900 pulses. The patient to patient variation in the number 
of pulses was associated with the size of the surface area treated, not 
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with the treatment indication. Treatment parameters used on each 
patient are listed in Table 1.   
 
Table 1.  Treatment Parameters and Follow-up Times
1 25 10,000 6 20.2 9
2 22 11,500 5 21 3
3 36 12,400 7 22.5 9
4 26 11,800 7 31 9
5 29 13,400 7 23 8
6 42 10,000 5 24.2 9
7 24 10,400 7 23.2 8
8 27 12,000 7 26.8 9
9 22 13,700 6 18.7 10
10 29 11,800 6 22 10
11 23 12,000 6 23.1 9
12 40 10,200 5 29 10
13 28 15,000 6 22.6 9
14 18 12,500 6 20.6 9
15 21 12,000 6 22.2 10
16 25 13,800 7 27.3 9
17 30 13,900 5 21.7 9
18 26 8,600 6 28.6 9
19 31 9,700 5 21 10
20 27 12,400 5 26.7 10
21 32 12,300 6 30.7 9
22 47 8,000 6 33 9
AVERAGE 28.64 11,700 6 24.5 9
Patient Age
Follow-up Post 
Final Treatment 
(months)
# of Days 
Between 
Treatments
# of 
Treatments
# of Pulses 
per 
Treatment
 
 
To optimize laser results, the skin was treated with 
microdermabrasion (MDA) throughout the sub-millisecond 1064 nm 
Nd:YAG  laser  treatment  series.  Ten  sessions  of  MDA  were  
administered with an interval of 7 to 10 days between each session. 
A minimum of 3 days was allowed between MDA and laser 
treatments.   
Following the MDA treatment, the whole face was treated with the 
sub-millisecond 1064 nm Nd:YAG laser. No additional passes were 
applied on the areas of atrophic scarring. The hand piece was held 1-
2 cm off the face with continuous motion to build heat and erythema 
in the treatment area prior to moving to an adjacent part of the face. 
The surface area for each treatment region was approximately 5 cm x 
5 cm. The total and average number of pulses per treatment, and the 
total number of treatments per patient are also shown in Table 1. 
Three independent physician reviewers (two dermatologists and one 
plastic surgeon) were asked to identify the before and after treatment 
photos which were presented to the physicians for assessment in 
random order.  After selecting the before and after image, reviewers 
were asked to rank the degree of improvement in scarring, texture 
and PIH using a four-point scale (0 = < 25%, 1 = 25-50%, 2 = 51-
75%, 3 = 76-100%).  Any indication which did not apply to a patient 
was marked as N/A. The median improvement score was calculated 
based on scores from all three reviewers.  When the before photo 
was incorrectly selected as the after photo (1 case only), the negative 
value of the improvement score was used in calculating the median 
score taking into account the magnitude of deterioration as assessed 
by the reviewer. This was done instead of excluding this case to 
avoid any bias in the data analysis. Patients were evaluated for 
erythema, edema, purpura, blistering, crusting, hypo- and hyper-
pigmentation, and scarring. Patients were also asked if they observed 
any adverse reaction of the above or any other skin reaction they 
consider adverse between visits. 
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Statistical Analysis 
 
Statistical analysis was performed using Minitab statistical package, 
version 15.1.20.0 (Minitab Inc., State College, Pennsylvania). For 
statistical testing, two-sided one-sample Wilcoxon signed rank test 
was used, and P values less than .05 were considered statistically 
significant. Additionally, the medians and spread of the data were 
displayed  in  box  plot  graph.  Kappa  agreement  analysis  was  
performed to measure the inter-reviewer reliability of before and 
after photos assessments and the kappa coefficient was reported.  
 
3.1.2. Post chickenpox scars treatment  
Regarding the Post-chickenpox scar group, Fifteen male patients 
aged 35 to 48 years (mean, 42 years) with Fitzpatrick skin type IV 
and V presented with a history of chickenpox infection 3 months 
earlier which left numerous scars over the face and forehead (Figure 
9 1a, 1c, and 2a). All patients reported the occurrence of skin lesions 
few  days  after  the  onset  of  the  fever.  This  was  followed  by  scab  
formation over the skin lesions which started to fall off within 10 
days of the onset of their appearance which resulted in scars. Gentian 
violet lotion or topical antibiotic ointment was applied topically over 
the  skin  lesions  and  antibiotic  was  administered  orally  for  1  week.  
No other intervention had been administered before the patients 
presented to us. Exclusion criteria included any prior trial for 
treatment of the scars, any concomitant systemic disease, and any 
active skin infection. 
Patients were referred to our clinic seeking treatment for their facial 
scars. Treatments were performed without topical anesthesia. No 
prophylactic therapy was used before or after treatment to control 
postinflammatory hyperpigmentation (PIH) resulting from laser 
treatments. 
The treatment regimen was started with MDA utilizing aluminum 
oxide crystals, followed by the session with the sub-millisecond 
1064-nm Nd:YAG laser. The MDA sessions were repeated every 7 
days for 8 sessions and the laser session was repeated every 3-4 
weeks for 5-6 sessions. A minimum of 3 days was allowed between 
MDA and laser treatments. Treatment was performed without topical 
anesthesia and no prophylactic therapy was administered before or 
after treatment to control post inflammatory hyperpigmentation 
(PIH) resulting from laser treatments. Treatment was performed over 
6 months. 
The following parameters used during laser treatments: 5-mm spot 
size, 14 J/cm2, and 0.4-millisecond pulse width with a repetition rate 
of 5 Hz. The face was divided into squares of 5 x 5 cm and laser 
pulses were delivered with a continuous motion. The hand piece was 
moved to the adjacent treatment area when erythema developed. 
Erythema was seen after an average of 500 pulses per treatment 
square. The laser treatment was conducted with no pre- or post- 
cooling of the skin while defocusing the hand piece 1 to 2 cm above 
the skin using multiple passes of the treatment area.  
The patients were followed up for a period ranging between 3 and 12 
months after the last laser session. There was no downtime or any 
incidence of adverse effects such as pigmentary changes or scab 
formation after the procedure. The post treatment erythema persisted 
for 20 to 30 minutes immediately after each laser session and 
completely faded away afterwards. The patients were asked to utilize 
sun block with at least SPF 30 in between the sessions. A 
questionnaire was administered to all participants 4 weeks after the 
last laser session regarding changes in scarring and skin texture as 
well  as  PIH.  These  3  parameters  were  graded  on  a  4-point  scale  
(2=marked improvement; 1=mild improvement; 0=no change; -
1=worsening). The same questionnaire also was administered to the 
treating physicians to grade changes observed in each participant. 
Photographs were taken before treatment and 3 months (or more) 
after the last laser session. Blinded assessments were performed by 3 
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independent physicians using before and after photographs 
(unlabeled) that were not arranged in chronologic order. Reviewers 
were asked to identify the before and after photographs and evaluate 
the degree of improvement or worsening observed in scarring, skin 
texture, and PIH using a 4-point scale (2=marked improvement; 
1=mild improvement; 0=no change; -1=worsening). No statistical 
analysis was performed.  
Adverse effects were evaluated immediately after each laser 
treatment and 2 and 4 weeks after each laser session.  
 
3.2. Treatment of warts 
3.2.1. Treatments of genital warts 
General examination for the whole body, including the oral mucosa, 
was done for signs of sexually transmitted diseases (STDs) (for 
example, vesicles, ulcers, warts, mucous patches, lymph node 
enlargement). 
Local genital examination was done while the patients were 
completely uncovered from the umbilicus down to the knee. The 
skin of the lower abdomen, penis, scrotum, perineum, perianal area, 
upper thighs, and the urethral meatus were inspected under good 
illumination for the presence of warts and other STDs. In all settings, 
patients with genital warts were examined and treated for other 
STDs.  Whenever  possible,  their  wives  or  current  sexual  partners  
were also offered examinations and treatments for macroscopically 
visible  warts  and  other  STDs.  Examination  of  the  anogenital  warts  
was done and the following data were recorded: site, number, type, 
area, presence of complications such as ulcerations or bleeding. The 
wart area was estimated as follows: the two largest perpendicular 
diameters were measured, and the wart area was defined as the 
product of the two measurements. 
Finally, a total of 174 adult males with 550 uncomplicated 
anogenital  warts  and  with  no  history  of  topical  or  systemic  therapy  
for warts during the last 2 months were included and treated by 
pulsed dye laser. A pulsed dye laser (585 nm, 450 ms pulse duration; 
Cynosure, USA) was used with the following parameters: spot size 
5–7 mm according to the size of the lesions, and fluence 9–10 J/cm2. 
Overlapping pulses were done, up to three to four pulses, until the 
appearance of grayish discoloration of the lesions which was an end 
point for lesion coagulation. 
Treatments were repeated every 2 weeks with a maximum of three 
sessions. Topical antibiotic ointments were prescribed between the 
sessions to be used for a period of 7–10 days following every 
session. The number of warts, and the area of warts at presentation 
and at the end of treatment was recorded. Any adverse reactions 
were also recorded. Patients were followed-up for at least 4 months 
after the warts had cleared. 
 
3.2.2. Treatments of plane warts 
Fifty patients with a total of 326 verrucae were enrolled in the study 
over 8 months period. They were 23 males and 27 females, with a 
mean age of 26.5 (12–41) years old. All patients were complaining 
of flat warts mainly on the forehead, cheeks, chin, neck, arms and 
the dorsum of the hands. Inclusion criteria included no treatment of 
lesions within the past month, and no history of constitutional or 
iatrogenic immunosuppression. All patients gave informed consent. 
The study was completed by 42 patients, which completion defined 
as clearance of all visible warts or a maximum of 3 treatment 
sessions on the same lesion. 
Treatment sessions consisted of treatment with the long pulsed Nd-
YAG laser (1064 nm, Coolglide, Cutera, RIT 220 Excl.) with 20–30 
msec pulse duration and fluence between 95–110 J/cm2, with 5,7 
mm spot size according to the size of the lesion, applying double or 
triple overlapping pulses. Our endpoint was light greyish 
discoloration of the lesion. 
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Following treatment, there was slight peri-lesional erythema. Very 
minimal heat sensation or sometimes slight burning pain was 
experienced especially in children. Topical anaesthetic cream of 5 % 
lidocaine and 3.5 % prilocaine was used only in cases of children or 
with patients of low pain threshold. Treatment sessions were carried 
every 2 weeks with a maximum of 3 sessions on the same lesion. All 
patients and health care providers wore protective eyewear and 
micropore laser masks. A smoke evacuator was used as a precaution 
against  potential  aerosolised  viral  particles.  Photographs  were  
obtained at the initial visit and at 3 months follow up after the last 
treatment session. 
  
4. RESULTS 
4.1. Treatments of scars       
4.1.1. Treatment of scars in dark skin types 
Blinded Photo Assessments  
Two reviewers correctly identified all photos (22/22).  The third 
reviewer incorrectly labeled one pair of before and after images and 
was not able to identify another pair of photos due to insufficient 
image quality (20/22).  The reviewers were highly consistent (inter-
reviewer reliability, kappa of 0.88) in identification of before and 
after photos (kappa coefficient: poor < 0.20, fair 0.21-0.40, moderate 
0.41-0.60, good 0.61-0.80, and very good 0.81-1.00). 
Of the sixty-six possible image reviews for each category (22 images 
each reviewed by 3 physicians), one was determined by one reviewer 
as insufficient quality to grade before and after.  Additionally, 4 
images were excluded from scarring analysis, 4 were excluded from 
texture analysis and 5 were excluded from pigment analysis.  Images 
were  excluded  due  to  insufficient  focus,  color  balance  and  or  
lighting.   
The results of the blinded photo assessments indicated clinically and 
statistically median improvement of 2 in scarring, 2.3 in texture and 
2  in  PIH  (P < 0.001). Figure 1 displays the median improvement 
scores and the variability of data for all three conditions (scale of 0-
3).   
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Figure 1. Median improvement of 2 in scarring, 2.3 in texture and 2 
in pigment based on blinded photo assessments by three reviewers. 
The box illustrates the 25th percentile to the 75th percentile with a 
line placed at the median (50% percentile). The bottom and top ends 
of whiskers show the minimum and maximum respectively.   
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Transient mild edema and erythema were observed in all patients 
and resolved within 2 hours after treatment. No transient or 
permanent complications such as blistering, crusting, purpura, 
scarring, transient or permanent hyper- or hypo-pigmentation were 
noted. There was no single patient who reported any adverse effects 
during or after the treatment sessions till the end of the follow up 
period in this study.    
 
4.1.2. Treatment of chickenpox scars  
All 15 participants were included in the analysis. The mean length of 
follow-up after the final laser session was 9.1 months. Questionnaire 
results demonstrated marked improvement in scarring, skin texture, 
and PIH as observed by participant and physician evaluation. Results 
of the participant assessment revealed mean scores in scarring, skin 
texture, and PIH of 1.8, 1.9, and 1.8, respectively. Physician 
evaluation of improvement revealed mean scores of 1.9, 1.9, and 1.8, 
respectively (2=marked improvement; 1=mild improvement). 
Participant and physician evaluation did not reveal scores of no 
change or worsening for the 3 parameters.  
For the blinded photographic assessments, all 3 reviewers correctly 
identified the chronology of 13 participant photographs (13/15). Of 
the 90 possible photograph reviews for each category (15 before and 
15 after photographs reviewed by 3 physicians), 2 were determined 
by 1 reviewer as insufficient quality to judge before and after 
photographs. Additionally, 4 photographs were excluded from skin 
texture analysis and 5 were excluded from PIH analysis. 
Photographs were excluded due to insufficient focus, color balance, 
or lighting. The results of the blinded photographic assessments 
indicated clinically significant improvements in scarring, skin 
texture, and PIH, with mean scores (based on all 3 reviewers) of 1.9, 
1.8, and 1.8, respectively (2=marked improvement; 1=mild 
improvement). None of the reviewers scored these parameters as no 
change or worsening.  
Transient mild edema and erythema were observed in all participants 
and  resolved  within  a  maximum  of  2  hours  after  treatment.  No  
transient or permanent complications such as blistering, crusting, 
purpura, scarring, or transient or permanent hyperpigmentation or 
hypopigmentation  were  noted  at  2  or  4  weeks.  None  of  the  
participants reported any adverse effects during or after the treatment 
sessions through the end of the follow-up period. 
 
4.2. Treatments of warts       
4.2.1. Treatments of genital warts    
The mean age of patients included was 31.33 + 4.7 years (range from 
22 to 49). The mean duration of lesions was 4.29 + 3.15 months 
(range from 1 to 48). The number of warts ranged from one to 14 per 
patient (average 3.82 + 4.33). Warts were frequently present with 
more than one lesion on one anatomical site. Warts were also present 
more frequently on different genital sites (104 patients, 59.78%) and 
on one genital site in 70 patients (40.22%). Among those latter 
patients, lesions were present on the penis in 39 (22.41%), on the 
scrotum in 11 (6.32%),  on the urethral meatus in four (2.29%), and 
on  the  Peri-anal  area  in  16  (9.2%).  The  mean  area  of  lesions  was  
26.9 mm2 and the area varied from 6 mm2 to 64 mm2. With regard to 
the morphological type of warts detected, it was predominantly 
condylomatous in 129 patients, papular in 31, keratotic in nine, and 
flat-topped papules in five patients. 
Complete clearance of 528 anogenital warts (96%) treated by pulsed 
dye laser occurred after one to three sessions. A few small warts of 
short duration occurring on one anatomical site cleared significantly 
after fewer sessions and resulted in earlier clearance. Patients with 
fewer than three and with an area less than 20 mm2 cleared most 
frequently after one session. Other factors such as a patient’s age and 
the morphological type did not affect the treatment results. 
Overlapping pulses (three to four) revealed better clearance of warts 
than single and even double pulsing. Side effects were infrequent 
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and  transient,  mostly  in  the  form  of  mild  pain  at  treatment  and  
transient hypopigmentation after treatment. Patients were followed-
up for at least 4 months (up to 9 months in some cases). 
Complete resolution and healing of skin without scaring or texture 
changes were found in the majority of cases. Lesion recurrence rate 
was 5%. Recurrence was defined as a new wart at the same site 
detected within the 4-month follow-up period after clearance of 
lesions. 
 
4.2.2. Treatments of plane warts  
Of the 50 patients initially enrolled, 42 patients with a total of 256 
warts  completed  the  study.  The  8  patients  who  withdrew,  were  for  
reasons unrelated to treatment. In the evaluation of treatment 
response, complete response was defined as complete absence of 
clinically apparent warts without any textural changes such as 
fibrosis or scar formation. Partial response was defined as greater 
than 50% reduction in wart size or number. 
Complete response was observed in 35 patients (83.3 %), while 
partial response was observed in 7 patients (16.7 %). No case 
showed no response to the lesion treatment. The mean number of 
treatments to achieve complete response was 2.00, while the mean 
number of treatments to achieve partial response was 2.65. 
Postoperative complications such as transient post inflammatory 
hypopigmentation was observed only in 4 cases and only 1 case 
experienced transient post inflammatory hyperpigmentation and was 
given hydroquinone 4% cream. The recurrence of warts during 
follow up period was reported only in 2 cases. As regards patient 
satisfaction, ninety two percent of all patients even those who 
experienced partial response were satisfied with the treatment they 
were given. 
 
 
 
5. DISCUSSION 
5.1. Laser treatment of scars 
Retrospective photographic analysis of 22 cases of scars in our study 
and 15 cases of post chickenpox scars indeed shows that sub-
millisecond 1064 nm Nd:YAG laser may be a viable treatment 
modality capable of generating improvement in texture, scarring and 
PIH secondary to the acne condition in darker skin types.  Blinded 
photo assessments by three independent physicians indicated that six 
treatments performed, on average, 24.5 days apart resulted in 
clinically and statistically significant improvement in atrophic 
scarring,  texture  and  PIH  in  patients  with  skin  types  III-VI.   High  
consistency between reviewers was observed in identifying before 
and after photos.   
It is noteworthy to state that The non-invasive treatments with the 
sub-millisecond 1064 nm Nd:YAG laser: (1) Improved the existing 
PIH from acne scarring; (2) Did not induce additional PIH; (3) Did 
not require pre- or post-treatment agents to control PIH in dark skin 
patients; (4) Did not require anesthetic.   
The percentage of subjects with skin types IV and V included in 
studies for the treatment of atrophic scarring are very limited 
compared to lighter skin types due to pigmentation concerns. Even 
with the use of hydroquinone pre- and post-treatment, a recently 
published prospective study of 15 subjects with skin types IV-VI and 
acne scarring using Er:YAG laser showed a 50% rate of the PIH. In 
the same study, the pain levels were reported to increase as the skin 
type went from IV to VI and as the number of passes went from 1 to 
8.   
One challenge faced in this retrospective study was not all patient 
photos had sufficient image quality. As a result, a couple of photos 
were excluded from the data analysis. The second challenge was the 
data only captured an overall percentage improvement without 
assessments of severity and types of scars at baseline and follow-up. 
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This was due to the lack of high resolution standardized photos.  In 
future studies, high resolution photos of scarring (using macro lens 
settings without flash or a three-dimensional optical profiling 
system) should be used for objective assessment of scar severity and 
type.  Lastly,  it  would  be  beneficial  to  collect  data  on  patient  
satisfaction in addition to physician assessments.   
The theory behind combining MDA treatments with laser treatments 
was to reduce the thickness of the stratum corneum thereby allowing 
greater light penetration to the papillary dermis. Thus, MDA 
treatments performed before the laser treatments were mild in 
intensity to prevent discomfort or complications from deep dermal 
abrasions.  The conservative MDA settings used in this study were 
not considered effective to treat acne scarring and PIH and were 
unlikely to have had an effect on the observed improvement. 
Nonetheless, randomized split face studies would be required to 
definitely determine whether MDA is necessary or has an additional 
benefit when used in combination with laser treatments.   
In previous studies, the sub-millisecond 1064 nm Nd:YAG laser 
therapy has been shown to stimulate collagen and to improve scar 
severity. However, no assessment has been performed on secondary 
improvement to texture and pigment. We hypothesize that the sub-
millisecond Nd:YAG laser works through two parallel actions to 
safely stimulate collagen and improve discoloration. The first 
mechanism involves discrete cellular damage caused by direct 
absorption in hemoglobin, melanin and water during each pulse and 
bulk heating from cumulative pulsing in a region. As a result, 
damage created through direct absorption and through sustained time 
at elevated temperature initiates a healing response, prompting 
collagen stimulation.   
Nd:YAG is absorbed by melanin and hemoglobin and is 
subsequently used for vascular and hair reduction treatments. Pulse 
durations in these treatments are in the 10-100ms range, roughly 30-
300 times longer than the pulse durations used in this study. The 
short pulse durations used in sub-millisecond treatment does not 
change the characteristics of chromophore absorption. At these short 
pulse durations, the laser energy is heating fine structures during 
each pulse, thus more selectively targeting the microvasculature in 
the papillary dermis and melanocytes within the epidermis without 
actually damaging the epidermis or larger vessels in the dermis.   
The second mechanism of action occurs through bulk heating. The 
laser uses a 5 mm spot pulsing at 5-10 Hz to deliver large amounts of 
energy in relatively short bursts to a finite area of tissue. Heat 
conducts to surrounding tissue over time to create bulk heating in 
each treatment. The degree of bulk heating is a function of total 
energy delivered per unit area per unit time. The goal during 
treatment is to deliver energy to an area of tissue faster than the body 
can extract the heat. For this reason, skin cooling is not desired 
during treatment. This bulk heating occurs gradually and non-
selectively through heat conduction, so no structures are specifically 
targeted. This allows for safe treatment, even on type VI skin.   
 
5.2. Laser treatment of warts 
Management of genital warts presents a problem of increasing 
magnitude to genitourinary medicine and Dermatology specialists. 
Choice of treatment is guided by patient preference, with 
consideration given to the patient’s age and ability to comply with 
moderately complicated directions, to the location and number of 
warts, and to the clinician’s training. Many conventional lines of 
therapy are used, the aim of which is to destroy the infected tissue; 
however, none are consistently effective, making genital warts a 
therapeutic challenge.  
Laser therapy had been used for the treatment of genital warts since 
the 1970s. CO2, argon, Nd:YAG and Er:YAG lasers have been used, 
especially for refractory genital warts, giant condyloma acuminatum 
  
 
10
or Buschke–Lowenstein tumor, with variable degrees of safety and 
efficacy. 
The pulsed dye laser was used initially for selective 
photothermolysis of vascular lesions, whereby the wavelength is 
selectively absorbed by the oxyhemoglobin, leading to destruction of 
the  vascular  component  of  the  tissue.  It  was  also  used  in  the  
management of other non-vascular lesions, depending on the 
photothermal effect of laser on the cutaneous tissue + its selective 
photothermolysis effect. The pulsed dye laser was used for the 
management of simple and recalcitrant verrucae vulgaris on different 
sites  of  the  body  using  fluencies  ranging  from  6  to  9  J/cm2. Other 
studies reported higher fluencies of 9.4 J/cm2 giving variable 
clearance rates. 
Tuncel et al. used the pulsed dye laser for the management of 
perianal warts in children with a fluence of 7.5 J/cm2. In our study, 
we used higher fluencies of 9–10 J/cm2, which ensured greater 
destruction of the vascular component of the lesions. 
The overlapping pulses increased the photothermal effect of the laser 
radiation leading to coagulation of the lesions and immediate graying 
of  the  warty  tissue.  The  technique  was  done  as  an  outpatient  
procedure and did not require any infiltration anesthesia as in 
electrocautery or surgery, which is another advantage of the pulsed 
dye laser in the treatment of genital warts. It is safe in comparison to 
the toxicity of podophyllotoxins, which are continuously 
investigated in an attempt to increase efficacy and decrease toxicity. 
In the light of results from our study, in which there was a significant 
number of patients presenting with multiple and/or large size 5 
lesions, complete resolution and healing of skin without scaring or 
texture changes were found in the majority of cases. This is in 
contrast with what is usually found with other traditional treatments 
such as electrocautery, surgical excision, cryotherapy or CO2 laser. 
Lesion clearance rate in our study was 96%, which is superior to that 
achieved by the more widely used treatment modalities (32–88%). 
Better results (smaller number of sessions and earlier clearance) 
were observed with lesions of short duration and in cases with a 
small  number  of  warts  occurring  on  one  anatomical  site.  On  the  
other hand, failure of treatment that occurred only in 4% of cases 
was observed in highly recalcitrant lesions with a large number of 
warts, which might be attributed to increased fibrosis and 
hyperkeratosis due to previous attempts of treatment. Lesion 
recurrence rate (5%) was also less than reported with other treatment 
modalities  (8–22%).  Post-treatment  recurrence  rates  are  not  well  
defined in most studies because in most cases either too few subjects 
have been studied or follow-up protocols had not been standardized. 
Common warts are hyperkeratotic papulonodules most often seen on 
the hand, arms and legs, but can seen anywhere on the glabrous skin. 
Common verrucae represent the most frequent clinical lesions 
produced by human papillomavirus. Verruca plana (flat warts) are 
less exophytic than common warts, frequently presenting as several 
or dozen of subtle papules 2–6 mm in diameter elevated above the 
surface less than a millimetre or so. These can be quite subtle, and 
may be missed by a casual observer. Pigmentary disturbances may 
be the most disturbing part of the flat wart infection to the patient. 
These lesions are frequently a problem on the face and the glabrous 
skin of non-immunocompromised individuals. At present, therapies 
aim to remove the lesion rather than specifically target human 
papillomavirus infection. Many different types of therapy have been 
used in treatment of verrucae. Commonly used methods of physical 
destruction include: electrodessication, cryosurgery and laser 
therapy. Chemical destruction is induced with salicylic acid, 
cantharidin, among others. Chemotherapeutic agents include 
podophillin resin and 5-fluorouracil. More recently 
immunomodulators such as interferon, systemic retinoids have been 
used. 
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Many types of lasers have been used for the management of warts. 
Carbon dioxyde laser vaporization for infected tissue was used. 
Results were not superior than the ordinary electrocautery which 
remove blindly the infected tissue as well and may sometimes lead to 
textural changes. Several investigators have demonstrated the 
efficacy of 585 nm pulsed dye laser in treating warts. The 
mechanism of action may be a result of intense heating of dermal 
vessels with collateral damage of virally infected keratinocytes. This 
theory is based on the presence of dilated and congested vessels at 
the base of most of verrucae and the mechanism of selective 
photothermolysis that result in targeting of haemoglobin by pulsed 
dye laser. To our knowledge, one report used KTP laser at 532 nm 
wavelength for treatment of recalcitrant pigmented warts, through 
selective photothermolysis and propagation of photoacoustic waves. 
Nd-YAG laser hyperthermia proved to be effective in treatment of 
resistant warts with significant clearance of the lesions and absence 
of viral particles, but it cannot be performed on very sensitive areas 
for example lesions on the face, neck or cheeks. Patients will not 
tolerate the procedure since it is done without anaesthesia and needs 
laser exposure time of 1-2 min in comparison to the pulsed lasers 
with micro and milliseconds pulse durations. Thus laser 
hyperthermia is not practical for large number of lesions. 
The Nd-YAG laser is one of the most versatile and interesting lasers 
in dermatological laser medicine. Almost no other laser has such a 
wide spectrum of applications. Depending on wavelength (1064 nm) 
and mode (continuous, Q-switched, long pulsed), it is applied on 
benign pigmented, vascular lesions and permanent hair reduction, 
due to the fact that 1064nm is absorbed by all the skin 
chromophores. 
Reports using long pulsed Nd-YAG laser as an effective line of 
treatment for vascular lesions such as telengietasia and venous lakes, 
encouraged us to use this laser system for thermal destruction of 
resistant flat warts. With its deeper penetration and lower absorption 
coefficient for melanin, there is less concern for collateral epidermal 
damage. 
Unlike ablative treatment modalities, with long pulsed Nd-YAG 
laser therapy, no wound was created, especially if the lesions were 
on exposed parts of the body mostly head and neck as in our study, 
thus avoiding prolonged post operative pain, crusting, scarring or 
downtime. 
Applying the pulsed mode of laser system, made the technique 
tolerable by the patients, most of whom returned to work or normal 
activities immediately postoperatively. There was no need for local 
infiltration anaesthesia (only topical anaesthetic cream was used for 
selected cases) was another advantage. The limited number of 
sessions up to three sessions in our protocol was to be comparable to 
other treatment modalities such as topical retinoids, chemical cautery 
also for the cost benefit wise. Most of the patients who experienced 
partial response was due to their large number of warty lesions, most 
of the lesions were not de novo, they were being treated before and 
lasted for more than six months. The risk of high incidence of post 
inflammatory hyperpigmentation is minimized by preferentially 
sparing epidermal pigment. The procedure proved to be acceptable 
and effective by the patients. Our results are comparable to pulsed 
dye laser treatment modalities which was another positive point, 
with an advantage over the pulsed dye laser of having no post laser 
purpura and no consumables such as dye kit. 
 
6. SUMMARY AND NEW FINDINGS 
Preliminary data collected in our retrospective study suggest that 
sub-millisecond 1064 nm Nd:YAG laser treatments are safe and 
effective for treating atrophic scarring in patients with darker skin 
types, delivering clinically and statistically significant results with 
reduced risk of pigment complications. This offers a new standard of 
care or first treatment option for patients with a high risk of 
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pigmentary complications. Prospective studies with the sub-
millisecond Nd:YAG laser alone are required to further assess 
treatment  outcomes  considering  the  effect  of  number  treatments  as  
well as to determine targeted treatment parameters for improved 
effects on scars of various severity and type. Further, randomized 
split face studies are needed to show the treatment effect and the 
incidence of PIH compared to non-treated and treated controls with 
alternative treatments.   
A further study was conducted to evaluate the safety and efficacy of 
the combination of the MDA and the sub-millisecond 1064-nm 
Nd:YAG laser in treatment of the post chickenpox scars in dark skin 
patients and the result of our study poved our treatment protocol to 
be safe and effective treatment modality for the postchickenpox 
scarring and inflammation induced hyperpigmentation in all skin 
types. In our study of genital warts in males, the pulsed dye laser has 
been found to be a safe, effective, and satisfactory treatment for 
genital  warts.  It  is  capable  of  selectively  destroying  warts  without  
damaging the surrounding skin. Regarding the plane warts, we 
concluded that Long Pulsed Nd-YAG laser can be added to the long 
list of traditional treatment of plane warts as an effective, safe and 
well tolerated method with minimal complications. We recommend 
the following inclusion criteria for long pulsed Nd-YAG laser 
treatment of plane warts: limited numbers of warty lesions, 
especially on very sensitive areas, lasted for less than six months 
with  no  previous  attempt  of  treatment.  In  Patients  with  previous  
criteria, long pulsed Nd-YAG laser would be significantly more 
costly effective than other treatment modalities.  
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